IBDEI046 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1656,1,5,0)
 ;;=5^LIPOMA NOS
 ;;^UTILITY(U,$J,358.3,1656,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,1657,0)
 ;;=724.02^^18^155^8
 ;;^UTILITY(U,$J,358.3,1657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1657,1,2,0)
 ;;=2^724.02
 ;;^UTILITY(U,$J,358.3,1657,1,5,0)
 ;;=5^LUMBAR STENOSIS
 ;;^UTILITY(U,$J,358.3,1657,2)
 ;;=^339732
 ;;^UTILITY(U,$J,358.3,1658,0)
 ;;=786.6^^18^155^9
 ;;^UTILITY(U,$J,358.3,1658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1658,1,2,0)
 ;;=2^786.6
 ;;^UTILITY(U,$J,358.3,1658,1,5,0)
 ;;=5^LUNG MASS
 ;;^UTILITY(U,$J,358.3,1658,2)
 ;;=^273380
 ;;^UTILITY(U,$J,358.3,1659,0)
 ;;=289.89^^18^156^1
 ;;^UTILITY(U,$J,358.3,1659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1659,1,2,0)
 ;;=2^289.89
 ;;^UTILITY(U,$J,358.3,1659,1,5,0)
 ;;=5^MACROCYTOSIS
 ;;^UTILITY(U,$J,358.3,1659,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,1660,0)
 ;;=263.9^^18^156^2
 ;;^UTILITY(U,$J,358.3,1660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1660,1,2,0)
 ;;=2^263.9
 ;;^UTILITY(U,$J,358.3,1660,1,5,0)
 ;;=5^MALNUTRITION
 ;;^UTILITY(U,$J,358.3,1660,2)
 ;;=^267900
 ;;^UTILITY(U,$J,358.3,1661,0)
 ;;=424.0^^18^156^5
 ;;^UTILITY(U,$J,358.3,1661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1661,1,2,0)
 ;;=2^424.0
 ;;^UTILITY(U,$J,358.3,1661,1,5,0)
 ;;=5^MITRAL VALVE PROLAPSE
 ;;^UTILITY(U,$J,358.3,1661,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,1662,0)
 ;;=340.^^18^156^6
 ;;^UTILITY(U,$J,358.3,1662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1662,1,2,0)
 ;;=2^340.
 ;;^UTILITY(U,$J,358.3,1662,1,5,0)
 ;;=5^MULTIPLE SCLEROSIS
 ;;^UTILITY(U,$J,358.3,1662,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,1663,0)
 ;;=410.90^^18^156^7
 ;;^UTILITY(U,$J,358.3,1663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1663,1,2,0)
 ;;=2^410.90
 ;;^UTILITY(U,$J,358.3,1663,1,5,0)
 ;;=5^MYOCARDIAL INFARCTION
 ;;^UTILITY(U,$J,358.3,1663,2)
 ;;=^269673
 ;;^UTILITY(U,$J,358.3,1664,0)
 ;;=424.0^^18^156^4
 ;;^UTILITY(U,$J,358.3,1664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1664,1,2,0)
 ;;=2^424.0
 ;;^UTILITY(U,$J,358.3,1664,1,5,0)
 ;;=5^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,1664,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,1665,0)
 ;;=995.83^^18^156^3
 ;;^UTILITY(U,$J,358.3,1665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1665,1,2,0)
 ;;=2^995.83
 ;;^UTILITY(U,$J,358.3,1665,1,5,0)
 ;;=5^MILITARY SEXUAL TRAUMA
 ;;^UTILITY(U,$J,358.3,1665,2)
 ;;=^304345
 ;;^UTILITY(U,$J,358.3,1666,0)
 ;;=787.01^^18^157^1
 ;;^UTILITY(U,$J,358.3,1666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1666,1,2,0)
 ;;=2^787.01
 ;;^UTILITY(U,$J,358.3,1666,1,5,0)
 ;;=5^NAUSEA W/ VOMITING
 ;;^UTILITY(U,$J,358.3,1666,2)
 ;;=^81644
 ;;^UTILITY(U,$J,358.3,1667,0)
 ;;=355.9^^18^157^2
 ;;^UTILITY(U,$J,358.3,1667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1667,1,2,0)
 ;;=2^355.9
 ;;^UTILITY(U,$J,358.3,1667,1,5,0)
 ;;=5^NEUROPATHY
 ;;^UTILITY(U,$J,358.3,1667,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,1668,0)
 ;;=357.2^^18^157^3
 ;;^UTILITY(U,$J,358.3,1668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1668,1,2,0)
 ;;=2^357.2
 ;;^UTILITY(U,$J,358.3,1668,1,5,0)
 ;;=5^NEUROPATHY,DIABETIC
 ;;^UTILITY(U,$J,358.3,1668,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,1669,0)
 ;;=356.9^^18^157^4
 ;;^UTILITY(U,$J,358.3,1669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1669,1,2,0)
 ;;=2^356.9
 ;;^UTILITY(U,$J,358.3,1669,1,5,0)
 ;;=5^NEUROPATHY,PERIPH
 ;;^UTILITY(U,$J,358.3,1669,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,1670,0)
 ;;=278.00^^18^157^5
 ;;^UTILITY(U,$J,358.3,1670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1670,1,2,0)
 ;;=2^278.00
 ;;^UTILITY(U,$J,358.3,1670,1,5,0)
 ;;=5^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,1670,2)
 ;;=^84823
